Bifidobacterium animalis subsp. lactis F1-7 Shows Multi-Pathway Potential for Metabolic and Intestinal Health

Bioyitech has introduced research findings onBifidobacterium animalis subsp. lactis F1-7, a Probiotic Strain with potential applications in metabolic health, intestinal wellness, and functional nutrition product development.

Research on F1-7 indicates that the strain may support multiple physiological pathways related to blood glucose regulation, glucose and lipid metabolism, gut hormone regulation, intestinal barrier function, inflammatory response, liver health, and bone health.

These findings provide scientific support for exploring F1-7 as a probiotic strain ingredient for B2B applications in Dietary Supplements, functional foods, probiotic formulations, and metabolic health products.

---

F1-7 may support intestinal motility and healthy bowel function.

Research indicates that F1-7 may influence several pathways associated with intestinal function.

The strain may enhance serotonin secretion, which is involved in intestinal motility and propulsive movement. F1-7 may also regulate aquaporin expression, potentially influencing water reabsorption and intestinal water balance.

In addition, F1-7 may promote intestinal mucin expression, helping maintain the intestinal mucus barrier and supporting a healthy intestinal environment.

---

F1-7 may support healthy blood glucose regulation, glucose metabolism, and insulin sensitivity-related pathways.

Research suggests that F1-7 may promote the secretion of intestinal hormones such as GLP-1 and PYY, which are involved in glucose metabolism and metabolic regulation.

The strain may also influence the PI3K/AKT signaling pathway and inflammatory pathways associated with metabolic health. These mechanisms may contribute to glucose utilization and the maintenance of pancreatic islet-related functions.

---

F1-7 may support healthy lipid metabolism and blood lipid balance.

F1-7 may participate in pathways associated with bile acid metabolism and cholesterol absorption.

Research findings indicate that F1-7 was associated with changes in serum lipid indicators and hepatic lipid accumulation in experimental models. The strain may also influence fecal bile acid levels, suggesting a potential role in gut-liver metabolic pathways.

Research models showed:

---

F1-7 may support liver health and antioxidant defense under alcohol-related metabolic stress.

Research indicates that F1-7 may influence the activity of enzymes involved in alcohol metabolism, including alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH).

The strain may also support antioxidant defense mechanisms and help regulate processes associated with lipid accumulation, oxidative stress, and inflammatory responses in experimental models.

---

F1-7 may support bone health and the maintenance of bone microarchitecture.

The gut microbiota plays an important role in the gut-bone axis. Research suggests that F1-7 may influence gut microbiota balance and inflammatory pathways associated with bone metabolism.

In experimental models, F1-7 was associated with reduced osteoclast hyperactivation and improvements in bone trabecular structure and the bone tissue microenvironment.

---

The research findings indicate that Bifidobacterium animalis subsp. lactis F1-7 may interact with multiple physiological pathways rather than focusing on a single health function.

Its potential mechanisms include:

• Blood glucose regulation

• Glucose metabolism

• Gut hormone regulation

• Lipid and cholesterol metabolism

• Bile acid metabolism

• Intestinal barrier maintenance

• Inflammatory response modulation

• Liver metabolic pathways

• Gut-bone axis regulation

This multi-pathway profile makes F1-7 a potential candidate for probiotic formulations targeting intestinal health, glycemic health, metabolic wellness, and functional nutrition.

---

For supplement manufacturers, functional food companies, and nutrition brands, Bifidobacterium animalis subsp. lactis F1-7 offers potential applications across several product categories.

Potential formulation areas include:

• Probiotic dietary supplements

• Blood glucose and glycemic health formulations

• Metabolic health products

• Gut health products

• Lipid metabolism support products

• Liver wellness formulations

• Bone health nutritional products

• Multi-strain probiotic blends

• Functional foods and beverages

Bioyitech provides B2B probiotic raw materials and customized probiotic formulation solutions for partners developing products based on specific market and formulation requirements.

---

Learn more about Bifidobacterium animalis subsp. lactis F1-7 probiotic powder, including its strain characteristics, potential applications, and formulation possibilities.

Bioyitech provides probiotic strain ingredients and customized OEM/ODM probiotic solutions for global dietary supplement, functional food, and nutrition product manufacturers.

[Explore Bifidobacterium animalis subsp. lactis F1-7 Product Page]

---

Bioyitech specializes in the development and supply of probiotic raw materials, single-strain probiotic ingredients, multi-strain probiotic premixes, and customized OEM/ODM probiotic solutions.

With a focus on probiotic science and functional nutrition, Bioyitech supports global partners in developing innovative solutions for intestinal health, metabolic wellness, and other nutrition-related applications.

---